Lab-score is a valuable predictor of serious bacterial infection in infants admitted to hospital

Josko Markic1, Tanja Kovacevic1, Vjekoslav Krzelj2

  • 1Department of Pediatrics, University Hospital Centre Split, Spinciceva 1, 21000, Split, Croatia. jmarkic@mefst.hr.

Insights

The Lab-score effectively identifies serious bacterial infections (SBI) in infants with fever without apparent source (FWAS). This validated tool aids early diagnosis, improving outcomes for young children presenting to the Emergency Department (ED).

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Disease Diagnostics
  • Biomarker Research

Background:

  • Fever without apparent source (FWAS) is a common reason for pediatric Emergency Department (ED) visits.
  • Early identification of serious bacterial infection (SBI) is crucial to prevent complications.
  • Current diagnostic methods, including clinical scores, have limitations in definitively predicting SBI.

Purpose of the Study:

  • To evaluate the performance of the Lab-score in predicting SBI in infants presenting with FWAS.
  • To assess the diagnostic accuracy of the Lab-score in well-appearing infants hospitalized for suspected SBI.

Main Methods:

  • The study assessed the Lab-score, a risk index based on procalcitonin (PCT), C-reactive protein (CRP), and urinary dipstick.
  • Performance was evaluated in infants ≤ 180 days old with FWAS.
  • Receiver operating characteristic (ROC) curve analysis was used to determine diagnostic utility.

Main Results:

  • White blood cells count (WBC), CRP, PCT, and a Lab-score ≥ 3 were confirmed as useful biomarkers for differentiating SBI from non-SBI.
  • The Lab-score demonstrated high diagnostic accuracy, with an Area Under the Curve (AUC) superior to other biomarkers.
  • In infants ≤ 180 days, the Lab-score achieved 67.7% sensitivity and 98.6% specificity for SBI prediction.
  • In infants ≤ 90 days, performance improved to 75% sensitivity and 97.7% specificity.

Conclusions:

  • The Lab-score is a valuable tool for detecting SBI in infants under 6 months with FWAS.
  • The study validates the Lab-score's high sensitivity and specificity in this pediatric population.
  • This risk index aids clinicians in the early and accurate diagnosis of serious infections in infants.